Mizuho Markets Americas’s Pfizer PFE Stock Holding History

Mizuho Markets Americas’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,887	Closed	-$199K	–	234
2025 Q3	$201K	Buy	+7,887	New	+$195K	﹤0.01%	189
2024 Q2	–	Sell	-134,947	Closed	-$3.74M	–	231
2024 Q1	$3.74M	Buy	+134,947	New	+$3.74M	0.09%	130

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mizuho Markets Americas's PFE Position: Q4 2025 in Review

Mizuho Markets Americas sold out of Pfizer (PFE) in Q4 2025, closing a stake of 7,887 shares — an estimated $199K sold.

Mizuho Markets Americas first reported a position in PFE in Q1 2024 and held it in 2 quarters. The position peaked at $3.74M in Q1 2024. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Mizuho Markets Americas reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Mizuho Markets Americas sold 7,887 Pfizer shares in Q4 2025, an estimated $199K.
Mizuho Markets Americas first reported a position in Pfizer in Q1 2024 and held it in 2 quarters.
Mizuho Markets Americas's Pfizer position peaked at $3.74M in Q1 2024.
2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Mizuho Markets Americas's 13F filing for Q4 2025, filed 6 Feb 2026.